Valuation: Cogstate Limited

Market Cap 493M 342M 299M 276M 255M 485M 32.65B 3.3B 1.3B 16.03B 1.28B 1.26B 55.53B P/E 2026 *
29.5x
P/E 2027 * 21.7x
Enterprise Value 435M 302M 264M 244M 226M 428M 28.86B 2.92B 1.14B 14.17B 1.14B 1.11B 49.09B EV / Sales 2026 *
5.01x
EV / Sales 2027 * 4.11x
Free-Float
54.16%
Yield 2026 *
1.13%
Yield 2027 * 1.41%

Last Transcript: Cogstate Limited

1 day+0.69%
1 week+5.84%
Current month+6.23%
1 month+3.94%
3 months+26.09%
6 months+34.88%
Current year+28.32%
1 week 2.57
Extreme 2.57
3
1 month 2.57
Extreme 2.57
3
Current year 2.01
Extreme 2.01
3
1 year 1.55
Extreme 1.55
3
3 years 0.8
Extreme 0.795
3
5 years 0.8
Extreme 0.795
3
10 years 0.16
Extreme 0.155
3
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - 17/12/1999
Chief Executive Officer - 01/12/2005
Director of Finance/CFO - 01/02/2021
Director TitleAgeSince
Director/Board Member - 01/03/2011
Chairman 67 03/11/2009
Director/Board Member - 20/01/2017
Date Insider Type Main position Quantity % Market Cap.
05-20Buy

Director

3,600 0.0021%
05-20Buy

Director

430 0.0003%
04-15
Myer & Myer Pty Ltd.
SellCompany 1,313,000 0.7679%
Change 5-day change 1-year change 3-year change Capi.($)
+0.69%+5.84%+77.91%+92.05% 340M
+0.77%+2.26%+3.13%+11.09% 50.44B
-2.30%-1.53%+385.95%+587.57% 40.63B
+0.28%+1.45%+26.24%-4.77% 34.88B
-2.00%-3.96%+17.30%+54.38% 33.67B
-2.09%-1.98%+3.21%+33.56% 26.29B
-1.72%+1.13% - - 17.11B
+0.01%-5.20%+63.21%+121.56% 15.29B
-7.90%-28.48%+40.37%+42.39% 10.62B
+0.90%-0.03%+14.38%+21.78% 13.74B
Average -1.43%-1.81%+70.19%+106.62% 24.3B
Weighted average by Cap. -1.23%-0.60%+84.29%+131.12%

Financials

2026 *2027 *
Net sales 86.95M 60.36M 52.81M 48.7M 45.06M 85.52M 5.76B 583M 229M 2.83B 227M 222M 9.8B 102M 70.99M 62.1M 57.27M 52.99M 101M 6.78B 686M 269M 3.33B 267M 261M 11.53B
Net income 16.9M 11.73M 10.26M 9.46M 8.76M 16.62M 1.12B 113M 44.43M 550M 44.04M 43.09M 1.9B 22.92M 15.91M 13.92M 12.84M 11.88M 22.55M 1.52B 154M 60.27M 746M 59.74M 58.45M 2.58B
Net Debt -57.17M -39.69M -34.72M -32.02M -29.63M -56.23M -3.79B -383M -150M -1.86B -149M -146M -6.44B -72.31M -50.2M -43.92M -40.5M -37.47M -71.12M -4.79B -485M -190M -2.35B -188M -184M -8.15B
Logo Cogstate Limited
Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
Employees
160
Date Price Change Volume
10/07/26 A$2.900 +0.69% 316,758
09/07/26 A$2.880 +7.06% 1,887,525
08/07/26 A$2.690 -3.93% 926,765
07/07/26 A$2.800 -1.06% 166,873
06/07/26 A$2.830 +3.28% 375,953
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
2.880AUD
Average target price
3.540AUD
Spread / Average Target
+22.92%

Quarterly revenue - Rate of surprise